NCT05017298View on ClinicalTrials.gov

Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 15, 2026

Conditions
Corona Virus InfectionCovid19
Interventions
BIOLOGICAL

Allogeneic adipose-derived stem cells

Culture expanded mesenchymal stem cells isolated from a patient's own abdominal fat tissue

Sponsors
All Listed Sponsors
lead

Celltex Therapeutics Corporation

INDUSTRY